当前位置: X-MOL 学术J. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Structure-Based Discovery of a Series of NSD2-PWWP1 Inhibitors
Journal of Medicinal Chemistry ( IF 6.8 ) Pub Date : 2022-06-15 , DOI: 10.1021/acs.jmedchem.2c00709
Na Li 1, 2 , Hong Yang 3 , Ke Liu 4 , Liwei Zhou 1 , Yuting Huang 3 , Danyan Cao 1 , Yanlian Li 1 , Yaoliang Sun 5 , Aisong Yu 3 , Zhiyan Du 1 , Feng Yu 4 , Ying Zhang 3 , Bingyang Wang 5 , Meiyu Geng 3, 6 , Jian Li 7 , Bing Xiong 1, 2 , Shilin Xu 5 , Xun Huang 3, 6 , Tongchao Liu 1
Affiliation  

Overexpression, point mutations, or translocations of protein lysine methyltransferase NSD2 occur in many types of cancer cells. Therefore, it was recognized as onco-protein and considered as a promising anticancer drug target. NSD2 consists of multiple domains including a SET catalytic domain and two PWWP domains binding to methylated histone proteins. Here, we reported our efforts to develop a series of NSD2-PWWP1 inhibitors, and further structure-based optimization resulted in a potent inhibitor 38, which has high selectivity toward the NSD2-PWWP1 domain. The detailed biological evaluation revealed that compound 38 can bind to NSD2-PWWP1 and then affect the expression of genes regulated by NSD2. The current discovery will provide a useful chemical probe to the future research in understanding the specific regulation mode of NSD2 by PWWP1 recognition and pave the way to develop potential drugs targeting NSD2 protein.

中文翻译:

基于结构的一系列 NSD2-PWWP1 抑制剂的发现

蛋白质赖氨酸甲基转移酶 NSD2 的过表达、点突变或易位发生在许多类型的癌细胞中。因此,它被认为是一种癌蛋白,被认为是一种很有前途的抗癌药物靶点。NSD2 由多个结构域组成,包括一个 SET 催化结构域和两个与甲基化组蛋白结合的 PWWP 结构域。在这里,我们报告了我们开发一系列 NSD2-PWWP1 抑制剂的努力,进一步基于结构的优化产生了一种有效的抑制剂38,它对 NSD2-PWWP1 结构域具有高选择性。详细的生物学评估表明,化合物38可以与 NSD2-PWWP1 结合,进而影响 NSD2 调控的基因的表达。目前的发现将为未来的研究提供有用的化学探针,以了解PWWP1识别对NSD2的特定调控模式,并为开发靶向NSD2蛋白的潜在药物铺平道路。
更新日期:2022-06-15
down
wechat
bug